Improving environmental protection in EU pharmaceutical legislation : recommendations for reducing adverse environmental impacts from human pharmaceuticals / by Daniela Gildemeister, Annika Buck, Arne Hein; Ines Rönnefahrt, Ina Ebert, Małgorzata Dębiak (German Environment Agency/Umweltbundesamt, DessauRoßlau) ; on behalf of the German Environment Agency ; publisher: Umweltbundesamt ; responsible unit: Section IV 2.2 Pharmaceuticals
Anzeigen / Download1.49 MB
Discovery
1819012115
URN
urn:nbn:de:gbv:3:2-919049
DOI
ISBN
ISSN
Beiträger
Körperschaft
Erschienen
Dessau-Roßlau : Umweltbundesamt, October 2022
Umfang
1 Online-Ressource (23 Seiten, 1,48 MB) : Illustrationen, Diagramme
Ausgabevermerk
Sprache
eng
Anmerkungen
Inhaltliche Zusammenfassung
In preparation of the revision of Directive 2001/83/ EC and Regulation (EC) No 726/2004, the German Environment Agency (UBA) proposes legal changes to reduce pharmaceutical residues in the environment. The proposals are based on UBA’s experiences as competent authority for the environmental risk assessment (ERA) of pharmaceuticals. Our overall aim is to ensure a comprehensive risk management system without compromising availability of medicines for patients. In this context we consider the recent EU strategy on pharmaceuticals and initiatives in connection with EU`s Green Deal particularly the Zero Pollution Ambition and the one substance one assessment approach.
Schriftenreihe
Scientific opinion paper ; October 2022 ppn:1703431049